Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5351
GraniteShares 2x Long QCOM Daily ETF
QCML
$53.9M
| $582K | ﹤0.01% |
+29,320
| New | +$680K |
2026 Q2
0 quarters
|
|
5352
Strive 500 ETF
STXF
$1.18B
| $580K | ﹤0.01% |
12,005
+1
| +0% | +$47 |
2023 Q4
10 quarters
|
|
5353
Peoples Bancorp of North Carolina
PEBK
$235M
| $576K | ﹤0.01% |
13,372
-3,107
| -19% | -$129K |
2013 Q4
50 quarters
|
|
5354
Evotec
EVO
$505M
| $576K | ﹤0.01% |
205,763
-53,981
| -21% | -$156K |
2021 Q4
18 quarters
|
|
5355
Ocugen
OCGN
$276M
| $575K | ﹤0.01% |
375,656
-302,250
| -45% | -$459K |
2020 Q2
24 quarters
|
|
5356
Barfresh Food Group
BRFH
$9.48M
| $574K | ﹤0.01% |
287,236
-15,999
| -5% | -$38.6K |
2022 Q1
17 quarters
|
|
5357
iShares Energy Storage & Materials ETF
IBAT
$60.5M
| $574K | ﹤0.01% |
12,746
+6,956
| +120% | +$297K |
2026 Q1
1 quarter
|
|
5358
BitGo Holdings
BTGO
$763M
| $574K | ﹤0.01% |
110,747
+74,061
| +202% | +$608K |
2026 Q1
1 quarter
|
|
5359
Relmada Therapeutics
RLMD
$341M
| $573K | ﹤0.01% |
82,823
-115,640
| -58% | -$808K |
2019 Q4
26 quarters
|
|
5360
Stereotaxis
STXS
$105M
| $571K | ﹤0.01% |
332,107
+201,304
| +154% | +$378K |
2019 Q4
26 quarters
|
|
5361
KVH Industries
KVHI
$109M
| $570K | ﹤0.01% |
57,554
-6,958
| -11% | -$66.6K |
2013 Q4
50 quarters
|
|
5362
Inspired Entertainment
INSE
$89.4M
| $568K | ﹤0.01% |
68,902
+13,871
| +25% | +$103K |
2021 Q1
21 quarters
|
|
5363
BV Financial
BVFL
$184M
| $567K | ﹤0.01% |
26,775
+4,968
| +23% | +$99.3K |
2023 Q3
11 quarters
|
|
5364
DELISTED
KORE Group Holdings
KORE
| $566K | ﹤0.01% |
61,356
-8,223
| -12% | -$75.5K |
2021 Q4
18 quarters
|
|
5365
Franklin Pennsylvania Municipal Income ETF
FTPA
$95.4M
| $564K | ﹤0.01% |
64,427
-1,181
| -2% | -$10.2K |
2025 Q4
2 quarters
|
|
5366
Atrium Therapeutics
RNA
$134M
| $564K | ﹤0.01% |
41,942
-123,094
| -75% | -$1.61M |
2026 Q1
1 quarter
|
|
5367
Alpha Teknova
TKNO
$408M
| $561K | ﹤0.01% |
98,799
-18,191
| -16% | -$72.2K |
2021 Q2
20 quarters
|
|
5368
Western New England Bancorp
WNEB
$272M
| $560K | ﹤0.01% |
39,170
-487
| -1% | -$6.65K |
2013 Q2
52 quarters
|
|
5369
Invesco DB Oil Fund
DBO
$304M
| $559K | ﹤0.01% |
31,672
-1,070
| -3% | -$22.3K |
2013 Q2
52 quarters
|
|
5370
Amplify Online Retail ETF
IBUY
$129M
| $557K | ﹤0.01% |
8,065
+181
| +2% | +$12.1K |
2017 Q3
35 quarters
|
|
5371
Sanara MedTech
SMTI
$322M
| $557K | ﹤0.01% |
23,628
+3,988
| +20% | +$82.5K |
2021 Q2
20 quarters
|
|
5372
Microvast
MVST
$219M
| $557K | ﹤0.01% |
476,208
-1,593,300
| -77% | -$2.46M |
2019 Q2
28 quarters
|
|
5373
Avalyn Pharma
AVLN
$1.09B
| $557K | ﹤0.01% |
+16,906
| New | +$488K |
2026 Q2
0 quarters
|
|
5374
NYLIM Candriam International Equity ETF
IQSI
$266M
| $555K | ﹤0.01% |
14,497
-2,360
| -14% | -$88.7K |
2021 Q2
20 quarters
|
|
5375
Douglas Elliman
DOUG
$135M
| $551K | ﹤0.01% |
311,335
-22,551
| -7% | -$40.4K |
2021 Q4
18 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.